908 Devices Inc. (NASDAQ: MASS) is a Healthcare company (Medical - Specialties) with a market capitalization of $390M. The Maz Rating grades it against the other companies in its sector.
908 Devices Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $9.39, 908 Devices Inc. trades at 5.8x sales and 2.5x book value. Over the last twelve months it generated about $67M of revenue and a net loss of $27M. It runs a gross margin of 50.8%, an operating margin of -43.0% and a net margin of -36.7%. It shows return on equity of -17.4%, return on invested capital of -16.0% and a free cash flow yield of 0.7%. On the balance sheet: a debt-to-equity ratio of 0.03 and a current ratio of 5.43. Over the past 52 weeks the share price ranged from $5.03 to $13.35, with a beta of 0.63.
908 Devices Inc. does not currently pay a dividend.
7 Wall Street analyst ratings cover the stock: 7 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.